Invention Grant
US08771745B2 Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
有权
前列腺素和前列腺酰胺药物递送系统及其眼内治疗用途
- Patent Title: Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
- Patent Title (中): 前列腺素和前列腺酰胺药物递送系统及其眼内治疗用途
-
Application No.: US13596904Application Date: 2012-08-28
-
Publication No.: US08771745B2Publication Date: 2014-07-08
- Inventor: Michael R. Robinson , Hui Liu , Patrick M. Hughes , Lon T. Spada , Alazar N. Ghebremeskel
- Applicant: Michael R. Robinson , Hui Liu , Patrick M. Hughes , Lon T. Spada , Alazar N. Ghebremeskel
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Laura L. Wine; Joel B. German; Debra D. Condino
- Priority: WOPCT200961798 20091023
- Main IPC: A61K9/14
- IPC: A61K9/14 ; A61K9/00
Abstract:
Biocompatible, bioerodible implants and microspheres include latanoprost and a biodegradable polymer effective, when placed intraocular (such as into the subtenon space) to treat glaucoma.
Public/Granted literature
- US20130017268A1 PROSTAGLANDIN AND PROSTAMIDE DRUG DELIVERY SYSTEMS AND INTRAOCULAR THERAPEUTIC USES THEREOF Public/Granted day:2013-01-17
Information query
